RIP2 polymorphisms in inflammatory bowel diseases

Inflammatory Bowel Diseases

Volumn 17, Issue 4, 2011, Pages 1055-

  Theibaut R ^a   Douchin, V ^a   Jung, C ^a   Merlin, F ^a   Colombel, J F ^b   Lemann, M ^c   Almer, S ^d   Tysk, C ^e   O'Morain, C ^f   Gassull, M ^g   Finkel, Y ^h   Zouali, H ⁱ   Pascoe, L ⁱ   Hugot, J P ^a  

^a UNIVERSITÉ PARIS DESCARTES   (France)

^b LILLE UNIVERSITY HOSPITAL   (France)

^c SAINT LOUIS HOSPITAL   (France)

^d LINKÖPING UNIVERSITY   (Sweden)

^e ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^f The University of Dublin   (Ireland)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h KAROLINSKA INSTITUTE   (Sweden)

ⁱ FONDATION JEAN DAUSSET CEPH   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CONTROLLED STUDY; CROHN DISEASE; ENTERITIS; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; LETTER; MAJOR CLINICAL STUDY; NOD2 GENE; PRIORITY JOURNAL; RIP2 GENE; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS;

EID: 79952478669     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21406     Document Type: Letter

References (6)

1. Hugot JP, Chamaillard M, Zouali H, et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature. 2001;411:599-603. (Pubitemid 32531408)
2. Girardin SE, Boneca IG, Viala J, et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J Biol Chem. 2003;278:8869-8872. (Pubitemid 36800360)
3. Inohara N, Ogura Y, Fontalba A, et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J Biol Chem. 2003;278:5509-5512. (Pubitemid 36800790)
4. Ogura Y, Inohara N, Benito A, et al. Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB. J Biol Chem. 2001;276:4812-4818.
5. Kobayashi KS, Chamaillard M, Ogura Y, et al. Nod2-dependent regulation of innate and adaptive immunity in the intestinal tract. Science. 2005;307:731-734. (Pubitemid 40194644)
6. McCarthy JV, Ni J, Dixit VM. RIP2 is a novel NF-kappaB-activating and cell death-inducing kinase. J Biol Chem. 1998;273:16968-16975. (Pubitemid 28311729)